A Randomised Comparison of Bicalutamide ('Casodex') 150 mg versus Placebo as Immediate Therapy Either Alone or as Adjuvant to Standard Care for Early Non-Metastatic Prostate Cancer - First Report from the Scandinavian Prostatic Cancer Group Study No. 6

Author： Iversen P.   Tammela T.L.J.   Vaage S.   Lukkarinen O.   Lodding P.   Bull-Njaa T.   Viitanen J.   Hoisaeter P.   Lundmo P.   Rasmussen F.   Johansson J.-E.   Persson B.-E.   Carroll K.   Scandinavian Prostatic Cancer Group SPCG  

Publisher： Elsevier

ISSN： 0302-2838

Source： European Urology, Vol.42, Iss.3, 2002-09, pp. : 204-211

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immediate Therapy in Early Prostate Cancer: Results from the Bicalutamide ('Casodex') EPC Programme

By Wirth M.   Iversen P.   McLeod D.   See W.  

European Urology Supplements, Vol. 1, Iss. 7, 2002-10 ,pp. : 20-25

Elsevier

Access to resources Recommend Favorite

Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression

By Wirth M.   Tyrrell C.   Wallace M.   Delaere K.P.   Sanchez-Chapado M.   Ramon J.   Hetherington J.   Pina F.   Heynes C.F.   Borchers T.M.   Morris T.   Stone A.  

Urology, Vol. 58, Iss. 2, 2001-08 ,pp. : 146-150

Elsevier

Access to resources Recommend Favorite

Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years

By Iversen P.   Tyrrell C.J.   Kaisary A.V.   Anderson J.B.   Baert L.   Tammela T.   Chamberlain M.   Carroll K.   Gotting-Smith K.   Blackledge G.R.P.  

Urology, Vol. 51, Iss. 3, 1998-03 ,pp. : 389-396

Elsevier

Access to resources Recommend Favorite

Parenteral Estrogen versus Combined Androgen Deprivation in the Treatment of Metastatic Prostatic Cancer – Scandinavian Prostatic Cancer Group (SPCG) Study No. 5

By Hedlund Per Olov   Ala-Opas Martti   Brekkan Einar   Damber Jan Erik   Damber Lena   Hagerman Inger   Haukaas Svein   Henriksson Peter   Iversen Peter   Pousette Åke   Rasmussen Finn   Salo Jaakko   Vaage Sigmund   Varenhorst Eberhard  

Scandinavian Journal of Urology and Nephrology, Vol. 36, Iss. 6, 2002-12 ,pp. : 405-413

Informa Healthcare

Access to resources Recommend Favorite

Quality of life in patients with skeletal metastases of prostate cancer and status prior to start of endocrine therapy: Results from the scandinavian prostate cancer group study 5

By Jønler Morten   Nielsen Ole Steen   Groenvold Mogens   Hedlund Per Olov   Damber Lena   Hedelin Hans   Waldén Mauritz  

Scandinavian Journal of Urology and Nephrology, Vol. 39, Iss. 1, 2005-02 ,pp. : 42-48

Informa Healthcare

Access to resources Recommend Favorite